US Senator Amy Klobuchar, released the statement below after the Merger Filing Fee Modernization Act, her bipartisan legislation with Senator Chuck Grassley (R-IA) to reform merger filing fees passed Congress as part of the government funding package.
The bill would update merger filing fees for the first time since 2001, lowering fees on smaller acquisitions and increasing them for the largest mergers, raising additional revenue that Congress can use to fund antitrust enforcement.
The legislation passed in the Senate also includes the State Antitrust Enforcement Venue Act, Klobuchar’s legislation with Senator Mike Lee (R-UT) to empower state antitrust enforcement by making it easier for state attorneys general litigating antitrust cases to remain in their selected courts. The bill has been endorsed by a coalition of State Attorney Generals.
Related: Klobuchar’s Push To Pass Antitrust Bill Meets Resistance
“We cannot expect our antitrust enforcers to take on the most powerful companies the world has ever known with duct tape and Band-Aids. By restructuring outdated merger filing fees, our bipartisan legislation will enable Congress to get much-needed resources to our antitrust enforcers so they can protect competition. I am also glad that this legislation includes my bill with Senator Lee to allow state attorneys general to more effectively enforce antitrust laws. This is an important victory, but it is clearly just the beginning of this fight. I will continue to work across the aisle to protect consumers and strengthen competition policy.”
Premerger filing fees have not changed since 2001. The current fee structure places too small a fee on larger deals – the fee for a $900 million deal is currently the same as the fee for a $60 billion deal. In recent years, funding for enforcement authorities has stagnated, failing to keep pace with the growth of the economy and increases in merger filings. The new fees will take effect in 2023.
Featured News
Judge Appoints Law Firms to Lead Consumer Antitrust Litigation Against Apple
Dec 22, 2024 by
CPI
Epic Health Systems Seeks Dismissal of Antitrust Suit Filed by Particle Health
Dec 22, 2024 by
CPI
Qualcomm Secures Partial Victory in Licensing Dispute with Arm, Jury Splits on Key Issues
Dec 22, 2024 by
CPI
Google Proposes Revised Revenue-Sharing Limits Amid Antitrust Battle
Dec 22, 2024 by
CPI
Japan’s Antitrust Authority Expected to Sanction Google Over Monopoly Practices
Dec 22, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 19, 2024 by
CPI
Effective Interoperability in Mobile Ecosystems: EU Competition Law Versus Regulation
Dec 19, 2024 by
Giuseppe Colangelo
The Use of Empirical Evidence in Antitrust: Trends, Challenges, and a Path Forward
Dec 19, 2024 by
Eliana Garces
Some Empirical Evidence on the Role of Presumptions and Evidentiary Standards on Antitrust (Under)Enforcement: Is the EC’s New Communication on Art.102 in the Right Direction?
Dec 19, 2024 by
Yannis Katsoulacos
The EC’s Draft Guidelines on the Application of Article 102 TFEU: An Economic Perspective
Dec 19, 2024 by
Benoit Durand